JD/MBA

Skematic Launches Workflow Management Solution for Regulated Industries

Retrieved on: 
Thursday, September 8, 2022
COO, University, CEO, Technology, Frustration, JPMorgan Chase, St. John's University School of Law, JD, Solution, AML, Saint John's University, Nationwide Mutual Insurance Company, JD/MBA, ARR, George Washington University, M1 Finance, University School, Compliance, Law, Smarsh, Science and technology in Asia, Risk, Environment, Forest Capital Museum State Park, Tutoring, Audit, Management, Indiana University

NEW YORK, Sept. 8, 2022 /PRNewswire-PRWeb/ -- New Solution Redefines Collaboration for Compliance Departments

Key Points: 
  • Skematic will elevate a firm's compliance footprint by automating processes and removing the frustration that exists in manual and analog functions.
  • With an emphasis on user experience, Skematic provides an end-to-end architecture specific to the dynamic needs of compliance and legal teams.
  • "We're providing the first workflow management solution designed specifically for compliance teams," said Skematic's CEO and Co-founder Charles Steerman.
  • Backed by more than three decades of regulatory technology experience, our mission is to provide the first workflow management solution designed specifically for regulated industries as viewed through the eyes of compliance professionals.

Campbell & Company and Joy-Raising Announce Strategic Partnership

Retrieved on: 
Wednesday, August 31, 2022
Social change, Partnership, University, Columbia University, Movement, CEO, University of Chicago Laboratory Schools, Trust, Strategic partnership, Dominican Republic, Kennedy Scholarship, Tesha, School, Culture, Barnard College, BIPOC, Consultant, Health, LinkedIn, Economics, JD/MBA, Education, Passaic Machine Works-Watts, Campbell & Company, Goal, Organization, Independent school, Chairperson, Eating, Instagram, Leadership, CC, Color, Girl, Social justice, Twitter, LLC, Founder, Ecosystem, Environment, Campbell, Bias, Management, Public relations, Northwestern University, Company, Facebook, Marketing

CHICAGO, Aug. 31, 2022 /PRNewswire-PRWeb/ -- Campbell & Company (CC), an employee-owned national consulting firm with expertise in fundraising, communications consulting, data strategy, and executive search, announces its strategic partnership with Joy-Raising, LLC, an international consultancy that offers expertise in philanthropy and diversity, equity, and inclusion.

Key Points: 
  • The CC+Joy-Raising strategic partnership will identify opportunities to proactively engage with Campbell & Company's clients to implement social change and promote racial equity across the fundraising ecosystem.
  • "We are thrilled to enter this partnership with Joy-Raising," states Kate Roosevelt, Campbell & Company's Co-President.
  • Joy-Raising was founded to help Campbell and Company and other organizations accomplish these goals, and fully realize their vision of inclusion.
  • Campbell & Company is a national consulting firm that helps organizations create greater impact through fundraising , executive search , communications , and strategic information services .

Joyce Farms Announces Leadership Transition

Retrieved on: 
Tuesday, August 2, 2022
Bird, CEO, VP, Certification, Poultry, JD/MBA, Board, Multimedia, North Carolina State University, Penn State Board of Trustees, Wake Forest University, GAP, Farm, Business administration, Poultry Products Inspection Act of 1957, Growth, Longevity, Hormone, Management, Clockmaker, Animal husbandry

WINSTON-SALEM, N.C., Aug. 2, 2022 /PRNewswire/ -- Joyce Farms, a premier provider of all-natural and heritage breed meat and poultry products, announced today that Ryan Joyce, formerly VP of Finance, and Stuart Joyce, formerly VP of Operations, have assumed the roles of President & CEO and Executive Vice President of Joyce Farms, respectively. Ron Joyce, who has served as President & CEO for the last 40 years, will remain Chairman of the Board and will play an active advisory role with the company moving forward.

Key Points: 
  • WINSTON-SALEM, N.C., Aug. 2, 2022 /PRNewswire/ -- Joyce Farms, a premier provider of all-natural and heritage breed meat and poultry products, announced today that Ryan Joyce, formerly VP of Finance, and Stuart Joyce, formerly VP of Operations, have assumed the roles of President & CEO and Executive Vice President of Joyce Farms, respectively.
  • "This will allow Joyce Farms to continue to grow as a family-owned business long into the future.
  • Ryan and Stuart represent the third generation of Joyces to lead Joyce Farms since it was founded in 1962 by their grandfather, Alvin Joyce.
  • Executive Vice President Stuart Joyce joined Joyce Farms after graduation from N.C. State Universityin 2010 with a Bachelor of Science degree in Agricultural Business Management.

Dequency launches music rights portal to create the first open, two-sided sync licensing marketplace

Retrieved on: 
Wednesday, July 6, 2022
Bitcoin, People, Efficiency, V1, Publishing, WarnerMedia, Weapons in Star Trek, CEO, Open Music Initiative, Cable & Wireless, OMI, Decentralized finance, GE, Fatboy Slim, Everything in Its Right Place, Project M, Terry McBride (CEO), JD/MBA, Foster the People, Walmart, Catalog, BMC Software, Harvard University, Berklee College of Music, CIO, Wireless, MIT, Technology, Blockchain, Newsweek, Big Gigantic, NFT, NEW, Board, Audio signal, Distinguishing, Cable, Turing Award, TuneCore, Multimedia, Microsoft, Cryptocurrency, Video game, Music, Sprint, Rykodisc, Fuze, Goldfish, Turtle, Music

NEW YORK, July 6, 2022 /PRNewswire/ -- Dequency has today launched its web3-powered music licensing marketplace, opening its portal to music rights holders everywhere, having completed a 4-month restricted beta phase.

Key Points: 
  • Decentralized music licensing marketplace allows owners to set fees; eliminates third parties from music licensing transactions to increase speed of payment, reduce costs.
  • NEW YORK, July 6, 2022 /PRNewswire/ -- Dequency has today launched its web3-powered music licensing marketplace, opening its portal to music rights holders everywhere, having completed a 4-month restricted beta phase.
  • Dequency is building a unique, decentralized music licensing marketplace for music rights holders and visual creators to connect, collaborate, and transact directly with one another.
  • About the v1 launch, Haldeman said: "Our goal is to create a decentralized sync marketplace where artists and music rights holders control their online licensing experience, thereby attracting the most discerning creators and copyright owners.

Matillion Appoints General Counsel and Chief Legal Officer

Retrieved on: 
Wednesday, May 25, 2022
Amazon Redshift, Financial Times, JPMorgan Chase, Efficiency, BigQuery, Industry, Bloomberg, University, General counsel, Organization, Goodwin, Time, Goldman Sachs, Microsoft, Twitter, Research Park at the University of Illinois Urbana-Champaign, Snowflake, LinkedIn, Growth, JD/MBA, Reuters, Publication, Security (finance)

DENVER and MANCHESTER, England, May 25, 2022 /PRNewswire/ -- Matillion, the leading enterprise cloud data integration platform, today announced the appointment of its General Counsel and Chief Legal Officer. Markus Bauman joins the company as it moves into a new phase of growth, having reached unicorn status late last year following its most recent Series E funding.

Key Points: 
  • He was most recently Partner and Head of European Strategic Relations at Goodwin, a global law firm serving the technology-driven economy, of which Matillion is a client.
  • As a well-respected figure in the legal and finance industries, he has been frequently quoted in publications including the Financial Times, Bloomberg, and Reuters.
  • Bringing Markus onboard as our general counsel and chief legal officer allows us to better serve Matillion users and helps us continue the integrity and responsibility in which we conduct our business," said Matillion CEOMatthew Scullion.
  • For further data transformation industry updates and perspectives, follow Matillion on Twitter @Matillion and LinkedIn at https://www.linkedin.com/company/matillion-limited/ .

Matillion Appoints General Counsel and Chief Legal Officer

Retrieved on: 
Wednesday, May 25, 2022
Amazon Redshift, Financial Times, Multimedia, JPMorgan Chase, Efficiency, BigQuery, Industry, Bloomberg, University, General counsel, Organization, Goodwin, Time, Goldman Sachs, Microsoft, Twitter, Research Park at the University of Illinois Urbana-Champaign, Snowflake, LinkedIn, Growth, JD/MBA, Reuters, Publication, Security (finance), Public relations

DENVER and MANCHESTER, England, May 25, 2022 /PRNewswire/ -- Matillion, the leading enterprise cloud data integration platform, today announced the appointment of its General Counsel and Chief Legal Officer. Markus Bauman joins the company as it moves into a new phase of growth, having reached unicorn status late last year following its most recent Series E funding.

Key Points: 
  • He was most recently Partner and Head of European Strategic Relations at Goodwin, a global law firm serving the technology-driven economy, of which Matillion is a client.
  • As a well-respected figure in the legal and finance industries, he has been frequently quoted in publications including the Financial Times, Bloomberg, and Reuters.
  • Bringing Markus onboard as our general counsel and chief legal officer allows us to better serve Matillion users and helps us continue the integrity and responsibility in which we conduct our business," said Matillion CEOMatthew Scullion.
  • For further data transformation industry updates and perspectives, follow Matillion on Twitter @Matillion and LinkedIn at https://www.linkedin.com/company/matillion-limited/ .

MediciNova to Participate in the B. Riley Neuro & Ophthalmology Conference

Retrieved on: 
Friday, April 22, 2022
Code, ALS, Annual report, Acute respiratory distress syndrome, Substance dependence, Idiopathic pulmonary fibrosis, Nasdaq, Ophthalmology, B. Riley Financial, Non-alcoholic fatty liver disease, DCM, Multiple sclerosis, U.S. Securities and Exchange Commission, Tokyo Stock Exchange, Security (finance), NASDAQ, JD/MBA, MD, MIF, Private Securities Litigation Reform Act, GLOBE, Doctor of Philosophy, Glioblastoma, Chemotherapy-induced peripheral neuropathy, Patient, Form 10-K, Intellectual property, Conference, CIPN, Amyotrophic lateral sclerosis, Failure, Form 8-K, PDE4, Neurodegeneration, NAFLD, IPF, FDA, MS, Risk, Pharmaceutical industry

MN-166 (ibudilast) is a small molecule compound that inhibits phosphodiesterase type-4 (PDE4) and inflammatory cytokines, including macrophage migration inhibitory factor (MIF).

Key Points: 
  • MN-166 (ibudilast) is a small molecule compound that inhibits phosphodiesterase type-4 (PDE4) and inflammatory cytokines, including macrophage migration inhibitory factor (MIF).
  • In addition, MN-166 (ibudilast) is being evaluated in patients that are at risk for developing acute respiratory distress syndrome (ARDS).
  • MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for inflammatory, fibrotic, and neurodegenerative diseases.
  • MediciNova disclaims any intent or obligation to revise or update these forward-looking statements.

Latham Further Expands Private Equity and M&A Practices in Houston

Retrieved on: 
Monday, April 11, 2022
Foreign Legal Consultant, JD/MBA, Scott, Law, Wharton School of the University of Pennsylvania, United Kingdom, Washington University in St. Louis, Multimedia, Washington University School of Law, Latham & Watkins, BS, Kingdom, Watkins, Miller, DeHeng Law Offices, Private equity, Mergers and acquisitions, Olin Business School, Willkie Farr & Gallagher, Lawyer, University, Partnership, Financial services

HOUSTON, April 11, 2022 /PRNewswire/ -- Latham & Watkins LLP1 is pleased to announce that Scott Miller has joined the firm's Houston office as a partner in the Private Equity and Mergers & Acquisitions Practices and member of the Corporate Department.

Key Points: 
  • HOUSTON, April 11, 2022 /PRNewswire/ -- Latham & Watkins LLP1 is pleased to announce that Scott Miller has joined the firm's Houston office as a partner in the Private Equity and Mergers & Acquisitions Practices and member of the Corporate Department.
  • Miller represents private equity firms and companies in a range of corporate, transactional, and securities law matters.
  • "Scott is an excellent addition to our expanding Private Equity and M&A Practices in Houston, and we are excited to welcome him to the firm," said Tim Fenn, Managing Partner of Latham's Houston office.
  • "Latham is the market leader in private equity and M&A and I am excited to join this world-class firm," said Miller.

MediciNova to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest

Retrieved on: 
Tuesday, March 15, 2022
Annual report, Code, NASH, Form 8-K, Idiopathic pulmonary fibrosis, Multiple sclerosis, GLOBE, Patient, JD/MBA, Nasdaq, Substance dependence, Failure, Private Securities Litigation Reform Act, Tokyo Stock Exchange, Conference, FDA, Fatty liver disease, Risk, Glioblastoma, DCM, Security (finance), EDT, NASDAQ, Amyotrophic lateral sclerosis, Form 10-K, ALS, IPF, U.S. Securities and Exchange Commission, Neurodegeneration, MS, Intellectual property, Pharmaceutical industry

MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for inflammatory, fibrotic and neurodegenerative diseases.

Key Points: 
  • MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for inflammatory, fibrotic and neurodegenerative diseases.
  • Based on two compounds, MN-166 (ibudilast) and MN-001 (tipelukast), with multiple mechanisms of action and strong safety profiles, MediciNova has 11 programs in clinical development.
  • These forward-looking statements include, without limitation, statements regarding the future development and efficacy of MN-166, MN-001, MN-221, and MN-029.
  • MediciNova disclaims any intent or obligation to revise or update these forward-looking statements.

HEXO Announces Refreshed Board of Directors; Reaches Agreement with Adam Arviv

Retrieved on: 
Tuesday, February 22, 2022
JD/MBA, Bachelor of Science in Nursing, Institutional Investor Advisory Services, SEDAR, Agreement, Company, EDGAR, CA, The Meeting, Senior, University, Power, TD Securities, Corporation, News director, TSX, CSE, CPA, Board, Merchant bank, Meeting, Investment, Mission statement, Bankruptcy, TD, Audit committee, CEO, Telephone, Board of directors, Dundee Corporation, NASDAQ, BA, PricewaterhouseCoopers, Pepperdine University, New Board, Molson Coors Beverage Company, Legislation, TSC Industries, Inc. v. Northway, Inc., Cannabis, GLOBE, Ownership, Canada Business Corporations Act, Associate, National Bank of Canada, Path, Intention, EST, Proxy, Holding company, Online gambling, Management, Bank, Drug, Security (finance), Circular, New, Science

HEXO to reduce size of board to seven members, with Arviv retaining right to nominate eighth member following the Company's upcoming shareholder meeting

Key Points: 
  • HEXO to reduce size of board to seven members, with Arviv retaining right to nominate eighth member following the Company's upcoming shareholder meeting
    GATINEAU, Quebec, Feb. 22, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the Company") today announced that it has entered into a transition agreement (the Agreement) with Adam Arviv and his fund, Kaos Capital, to refresh the Companys board of directors (the Board), effective immediately.
  • The Company has also agreed to appoint an eighth director to the Board and reasonably acceptable to the Board after the Meeting.
  • I look forward to working with the refreshed board as we build the companys next chapter and deliver on the Path Forward.
  • Adam Arviv and his affiliates have agreed to support the refreshed board slate at the Meeting.